Neurobrave

Company Overview

Snapshot

Founded in July 2020 by Dror Talisman and Oleg Aryutkin, Neurobrave operates with 11–50 employees. The company has raised a total of $3M across 4 funding rounds from 6 investors. In May 2024, Neurobrave secured a grant from the Google AI Startup Fund.

Business overview

Neurobrave develops a standardized software solution, NeuroSpeed OS, for analyzing neural biomarkers and insights. The company leverages cloud-based infrastructure, advanced signal processing, and proprietary deep neural network algorithms. Neurobrave's technology is designed to work with various hardware, including smartphones, smartwatches, and other wearables, serving the Health Tech & Life Sciences sector by aiming to reduce costs and accelerate time to market for neuroscience ventures.

Strategic signal

In April 2024, Neurobrave partnered with Sourasky Medical Center on a generative AI project. This collaboration signals a strategic move to integrate advanced AI into medical applications, potentially enhancing the company's offerings in neural biomarker analysis and validating its technology within a clinical setting, which could attract further investment and partnerships in the health tech space.

Company Intelligence Q&A

What is Neurobrave's core product?

Neurobrave's core product is NeuroSpeed OS, a standardized software solution that utilizes cloud-based infrastructure, advanced signal processing, and proprietary deep neural network algorithms to analyze neural biomarkers and insights from various wearables.

When was Neurobrave founded and by whom?

Neurobrave was founded in July 2020 by Dror Talisman, who serves as Co-founder & CEO, and Oleg Aryutkin, Co-founder & CTO.

What was a significant recent partnership for Neurobrave?

In April 2024, Neurobrave partnered with Sourasky Medical Center on a generative AI project, focusing on advancing its technology within a medical context.

Which investors participated in Neurobrave's November 2022 funding round?

In November 2022, Neurobrave received investment from Italian Angels for Growth and VentureIsrael.